Friday, August 19, 2011
Four BioTime embryonic stem cell lines OK'd for NIH registry
Four embryonic stem cell lines developed by a subsidiary of BioTime Inc. were approved by the National Institute of Health for use by stem cell researchers in federally funded research, the company said Friday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment